Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
81 hedge funds and large institutions have $2.09B invested in Zymergen Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
84% less call options, than puts
Call options by funds: $504K | Put options by funds: $3.17M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
+$1.05B |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$111M |
| 3 |
BAMCO Inc
New York
|
+$105M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$103M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$67.5M |
Top Sellers
ZY Hedge Fund Activity: Q2 2021 in Review
81 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q2 2021, worth a combined $2.09B.
Buyers outnumbered sellers: 81 funds opened new ZY positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SB Investment Advisers (UK), opening a new position worth an estimated $1.05B.
- 81 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $2.09B of Zymergen Inc. Common Stock stock for Q2 2021.
- 81 funds opened new Zymergen Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +81 holders.
- The largest Zymergen Inc. Common Stock buyer in Q2 2021 was SB Investment Advisers (UK), an estimated $1.05B added.
Based on aggregated 13F filings for Q2 2021.